Taysha Gene Therapies Inc · TSHA.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $343.32M − (Liabilities $96.38M + Equity $246.94M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$319.77M
93.1%
$180.73M
130.0%
Assets
PPE
$16.18M
4.7%
$309.00K
1.9%
Assets
Other
$7.38M
2.1%
$1.92M
35.1%
Liabilities + Equity
Long-term debt
$50.11M
14.6%
$6.16M
14.0%
Liabilities + Equity
Other liabilities
$46.28M
13.5%
$1.38M
3.1%
Liabilities + Equity
Equity
$246.94M
71.9%
$175.41M
245.2%